Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
akcea therapeutics
alnylam pharmaceuticals
boston
2
×
boston blog main
boston top stories
fda
hereditary transthyretin amyloidosis
2
×
inotersen
life sciences
national blog main
national top stories
new york blog main
new york top stories
onpattro
patisiran
pfizer
san diego blog main
san diego top stories
tafamidis
2
×
andrew fire
clinical trials
craig mello
drugs
european medicines agency
harvard pilgrim health care
institute for clinical and economic review
john maraganore
nobel prize
rna interference
san francisco blog main
san francisco top stories
vyndaqel
What
alnylam
drug
2
×
fda
medicine
rnai
afternoon
alnylam’s
approved
approves
cells
ema
employ
europe
follows
gene
gets
harmful
history
hits
interference
landmark
make
making
method
mute
ok
onpattro
patisiran
pharmaceuticals
protein
rna
specifically
uses
way
Language
Current search:
boston
×
" hereditary transthyretin amyloidosis "
×
drug
×
tafamidis
×
@xconomy.com
6 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
6 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug